tradmap

MTEX MANNATECH INC

$7.28 -2.93%

Updated

Healthcare · Medicinal Chemicals & Botanical Products

MANNATECH INC (MTEX) is a healthcare company in the Medicinal Chemicals & Botanical Products industry, with a market capitalization of $14 million. Shares last traded at $7.28, 51.5% below their 52-week high. Over the past year the stock is down 13.6%. Net profit margin is -6.9%, above the peer median of -8.5%. Revenue declined 8.3% year over year. The shares yield 11.0% in dividends.

Market Cap
$14M
Shares Out
1.9M
EPS (TTM)
$-3.62
P/E Ratio
P/S Ratio
0.13
P/B Ratio
Dividend / Share
$0.80
Dividend Yield
10.99%
52-Week High
$15.00
52-Week Low
$3.82
Volume
714
Avg Vol (3m)
668.286

Performance

1W
+12.87%
1M
+66.97%
3M
+47.07%
6M
-20.61%
YTD
-14.85%
1Y
-13.64%

Daily candles · volume · SMA(20)/SMA(50) · Databento EQUS.MINI.

Technicals

RSI (14)
67.64
SMA (50)
$5.47
SMA (200)
$7.23
Price vs SMA50
+33.09%
Price vs SMA200
+0.69%
ATR (14)
$0.42

Full technical analysis (26 indicators, D/W/M) →

Financials

Revenue
$107M
Net Income
$-7M
Gross Margin
76.1%
Operating Margin
2.5%
Net Margin
-6.9%
Return on Equity
149.0%
Return on Assets
-27.0%
Current Ratio
1.15
Debt / Equity
-0.55
Revenue Growth (YoY)
-8.3%

Latest reported annual period ending 2026-06-30 · SEC EDGAR/XBRL.

Full financials — revenue, cash flow & debt over time →

MTEX Dividend History

Dividend / share (TTM)
$0.80
Dividend yield
10.99%
Per-share growth (5y CAGR)
-19.9%
Fiscal year endTotal dividends paidPer share*Payout ratio
2023-12-31 $1M $0.00
2022-12-31 $2M $0.00
2021-12-31 $4M $0.00 44%
2020-12-31 $3M $0.00 54%
2019-12-31 $1M $0.00 36%
2018-12-31 $3M $0.00
2017-12-31 $1M $0.00
2016-12-31 $1M $0.00

*Per share derived as total dividends paid ÷ weighted diluted shares (SEC EDGAR/XBRL annual cash-flow facts). Reported history — not a forecast of future dividends.

Compare payers on the highest-dividend-yield screener.

Recent earnings

PeriodEPS (diluted)Reported
Q2 2026 $1.02 2026-08-12
Q1 2026 $0.49 2026-05-14
FY 2025 $-8.00 2026-04-15
Q3 2025 $-2.06 2025-11-12
Q2 2026 $-3.07 2026-08-12
Q1 2026 $-0.80 2026-05-14

Full earnings history →

Medicinal Chemicals & Botanical Products peers

MTEX vs 14 industry peers (Medicinal Chemicals & Botanical Products), by market cap. Updated

P/S vs peers
0.13 / 0.29 med
-55% discount
Net margin vs peers
-6.9% / -8.5% med
above median
1–14 of 14
DFTXDefinium Therapeutics, Inc.$5.1B-14.43-2.40%
TRLVTrulieve Cannabis Corp.$2.3B-4.862.03-41.8%+2.56%
TLRYTilray Brands$616M-5.070.67-13.3%+0.11%
USNAUSANA HEALTH SCIENCES INC$267M-12.030.29-2.4%-1.30%
NAGENiagen Bioscience, Inc.$246M15.411.9112.4%-1.89%
FTLFFITLIFE BRANDS, INC.$93M14.860.916.2%-3.10%
BTMDbiote Corp.$46M7.820.253.2%-9.91%
MTEXMANNATECH INC$14M-1.900.13-6.9%-2.93%
NAIINATURAL ALTERNATIVES INTERNATIONAL INC$12M-0.860.09-10.1%-0.47%
SNYRSynergy CHC Corp.$2M-0.100.06-57.0%-2.03%
CRONCronos Group39.1%+0.46%
CGCCanopy Growth-80.4%+0.27%
GLASGlass House Brands Inc.-16.3%+3.61%
IMCCIM Cannabis Corp.-27.57%

Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.